ARIAD Pharmaceuticals, Inc. (ARIA) - NASDAQ
From other sites
Company Description
ARIAD Pharmaceuticals, Inc. operates as an oncology company which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. Its products includes Iclusig (ponatinib), Brigatinib (previously known as AP26113), and AP32788. The company was... More
Sector: Healthcare
Industry: Biotechnology
Country: United States